Form 4: Boston Scientific EVP John Bradley Sorenson Reports Stock Sale
SEC Filing
John Bradley Sorenson, EVP of Global Operations at Boston Scientific, reports the sale of 6,528 shares of common stock at a price of $104.97 per share.
Summary
- John Bradley Sorenson, an EVP at Boston Scientific, reported a transaction involving the company's common stock on February 7, 2025.
- Sorenson sold 6,528 shares at a price of $104.97 per share.
- Following the transaction, Sorenson directly owns 26,449 shares of Boston Scientific common stock.
- The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of an insider transaction under a pre-existing trading plan.
Industry Context
This filing is a routine disclosure of an insider transaction. It's common for executives to have pre-arranged trading plans to avoid accusations of trading on inside information.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale under a pre-established trading plan.
Key Dates
| Date | Description |
|---|---|
| 08/09/2024 | Date of adoption of the Rule 10b5-1 trading plan. |
| 02/07/2025 | Date of the stock sale transaction. |
| 02/10/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.